As on Wednesday, Cassava Sciences Inc (NASDAQ: SAVA) started slowly as it slid -3.50% to $24.51, before settling in for the price of $25.40 at the close. Taking a more long-term approach, SAVA posted a 52-week range of $12.32-$32.10.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -30.45%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.54%. This publicly-traded company’s shares outstanding now amounts to $42.24 million, simultaneously with a float of $40.05 million. The organization now has a market capitalization sitting at $1.06 billion. At the time of writing, stock’s 50-day Moving Average stood at $22.17, while the 200-day Moving Average is $21.40.
Cassava Sciences Inc (SAVA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Cassava Sciences Inc’s current insider ownership accounts for 7.34%, in contrast to 32.70% institutional ownership. According to the most recent insider trade that took place on Aug 23 ’23, this organization’s Director bought 30,000 shares at the rate of 17.45, making the entire transaction reach 523,500 in total value, affecting insider ownership by 886,851. Preceding that transaction, on Aug 22 ’23, Company’s Director bought 16,571 for 16.65, making the whole transaction’s value amount to 275,907. This particular insider is now the holder of 293,477 in total.
Cassava Sciences Inc (SAVA) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/30/2023, the company posted -$0.5 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.52) by $0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
Cassava Sciences Inc’s EPS increase for this current 12-month fiscal period is 7.54% and is forecasted to reach -0.47 in the upcoming year.
Cassava Sciences Inc (NASDAQ: SAVA) Trading Performance Indicators
Let’s observe the current performance indicators for Cassava Sciences Inc (SAVA). It’s Quick Ratio in the last reported quarter now stands at 9.13. The Stock has managed to achieve an average true range (ATR) of 1.29.
In the same vein, SAVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.32, a figure that is expected to reach -0.46 in the next quarter, and analysts are predicting that it will be -0.47 at the market close of one year from today.
Technical Analysis of Cassava Sciences Inc (SAVA)
Through scrutinizing the latest numbers posted by the [Cassava Sciences Inc, SAVA], it can be observed that its last 5-days Average volume of 1.09 million was better the volume of 0.71 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 89.16% While, its Average True Range was 1.36.
Raw Stochastic average of Cassava Sciences Inc (SAVA) in the period of the previous 100 days is set at 45.47%, which indicates a major fall in contrast to 82.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 70.33% that was higher than 64.96% volatility it exhibited in the past 100-days period.
